has been cited by the following article(s):
|
[1]
|
Effect of aripiprazole on promoting cognitive function and enhancing clinical efficacy in patients with first-episode depression on escitalopram: A randomized controlled trial
Journal of Affective Disorders,
2024
DOI:10.1016/j.jad.2023.10.038
|
|
|
|
|
[2]
|
Implications of Cognitive Impairment on Several Aspects of Functionality and Quality of Life in Major Depressed Patients
Journal of Evidence-Based Psychotherapies,
2022
DOI:10.24193/jebp.2022.2.17
|
|
|
|
|
[3]
|
Cognitive Outcomes with Sequential Escitalopram Monotherapy and Adjunctive Aripiprazole Treatment in Major Depressive Disorder: A Canadian Biomarker Integration Network in Depression (CAN-BIND-1) Report
CNS Drugs,
2021
DOI:10.1007/s40263-021-00793-1
|
|
|
|
|
[4]
|
Cognitive Function in a Randomized Trial of Evolocumab
New England Journal of Medicine,
2017
DOI:10.1056/NEJMoa1701131
|
|
|
|
|
[5]
|
Cognitive Dysfunction in Major Depressive Disorder: Assessment, Impact, and Management
Focus,
2016
DOI:10.1176/appi.focus.20150043
|
|
|
|
|
[6]
|
Cognitive Impairment in Major Depressive Disorder
2015
DOI:10.1017/CBO9781139860567.002
|
|
|
|
|
[7]
|
Cognitive Impairment in Major Depressive Disorder
2015
DOI:10.1017/CBO9781139860567.011
|
|
|
|